Goldsmith M - Search Results

1

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.

Kon E, Levy Y, Elia U, Cohen H, Hazan-Halevy I, Aftalion M, Ezra A, Bar-Haim E, Naidu GS, Diesendruck Y, Rotem S, Ad-El N, Goldsmith M, Mamroud E, Peer D, Cohen O. Kon E, et al. Among authors: goldsmith m. Sci Adv. 2023 Mar 10;9(10):eadg1036. doi: 10.1126/sciadv.adg1036. Epub 2023 Mar 8. Sci Adv. 2023. PMID: 36888708 Free PMC article.

2

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach.

Solmesky LJ, Shuman M, Goldsmith M, Weil M, Peer D. Solmesky LJ, et al. Among authors: goldsmith m. Nanotechnology. 2011 Dec 9;22(49):494016. doi: 10.1088/0957-4484/22/49/494016. Epub 2011 Nov 21. Nanotechnology. 2011. PMID: 22101838

3

Grand challenges in modulating the immune response with RNAi nanomedicines.

Goldsmith M, Mizrahy S, Peer D. Goldsmith M, et al. Nanomedicine (Lond). 2011 Dec;6(10):1771-85. doi: 10.2217/nnm.11.162. Nanomedicine (Lond). 2011. PMID: 22122585

4

Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.

Landesman-Milo D, Goldsmith M, Leviatan Ben-Arye S, Witenberg B, Brown E, Leibovitch S, Azriel S, Tabak S, Morad V, Peer D. Landesman-Milo D, et al. Among authors: goldsmith m. Cancer Lett. 2013 Jul 1;334(2):221-7. doi: 10.1016/j.canlet.2012.08.024. Epub 2012 Aug 27. Cancer Lett. 2013. PMID: 22935680

5

Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.

Mizrahy S, Goldsmith M, Leviatan-Ben-Arye S, Kisin-Finfer E, Redy O, Srinivasan S, Shabat D, Godin B, Peer D. Mizrahy S, et al. Among authors: goldsmith m. Nanoscale. 2014 Apr 7;6(7):3742-52. doi: 10.1039/c3nr06102g. Nanoscale. 2014. PMID: 24569711

6

Precision nanomedicine in neurodegenerative diseases.

Goldsmith M, Abramovitz L, Peer D. Goldsmith M, et al. ACS Nano. 2014 Mar 25;8(3):1958-65. doi: 10.1021/nn501292z. ACS Nano. 2014. PMID: 24660817

7

Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.

Cohen ZR, Ramishetti S, Peshes-Yaloz N, Goldsmith M, Wohl A, Zibly Z, Peer D. Cohen ZR, et al. Among authors: goldsmith m. ACS Nano. 2015 Feb 24;9(2):1581-91. doi: 10.1021/nn506248s. Epub 2015 Jan 8. ACS Nano. 2015. PMID: 25558928

8

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Weinstein S, Toker IA, Emmanuel R, Ramishetti S, Hazan-Halevy I, Rosenblum D, Goldsmith M, Abraham A, Benjamini O, Bairey O, Raanani P, Nagler A, Lieberman J, Peer D. Weinstein S, et al. Among authors: goldsmith m. Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E16-22. doi: 10.1073/pnas.1519273113. Epub 2015 Dec 23. Proc Natl Acad Sci U S A. 2016. PMID: 26699502 Free PMC article.

9

Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte Capsules.

Zyuzin MV, Díez P, Goldsmith M, Carregal-Romero S, Teodosio C, Rejman J, Feliu N, Escudero A, Almendral MJ, Linne U, Peer D, Fuentes M, Parak WJ. Zyuzin MV, et al. Among authors: goldsmith m. Bioconjug Chem. 2017 Feb 15;28(2):556-564. doi: 10.1021/acs.bioconjchem.6b00657. Epub 2017 Jan 20. Bioconjug Chem. 2017. PMID: 28040889

10

A modular platform for targeted RNAi therapeutics.

Kedmi R, Veiga N, Ramishetti S, Goldsmith M, Rosenblum D, Dammes N, Hazan-Halevy I, Nahary L, Leviatan-Ben-Arye S, Harlev M, Behlke M, Benhar I, Lieberman J, Peer D. Kedmi R, et al. Among authors: goldsmith m. Nat Nanotechnol. 2018 Mar;13(3):214-219. doi: 10.1038/s41565-017-0043-5. Epub 2018 Jan 29. Nat Nanotechnol. 2018. PMID: 29379205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

810 results

Search Page